This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kling, J. PARP inhibitors blaze a trail in difficult-to-treat cancers. Nat Biotechnol 27, 784–785 (2009). https://doi.org/10.1038/nbt0909-784
Issue Date:
DOI: https://doi.org/10.1038/nbt0909-784
- Springer Nature America, Inc.
This article is cited by
-
Hyper-active non-homologous end joining selects for synthetic lethality resistant and pathological Fanconi anemia hematopoietic stem and progenitor cells
Scientific Reports (2016)
-
PARP inhibitors stumble in breast cancer
Nature Biotechnology (2011)
-
PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?
Breast Cancer Research (2009)